Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy
1 other identifier
observational
94
1 country
1
Brief Summary
The relationship between the surgical outcome of vitreous surgery for proliferative diabetic retinopathy and the compliance to ophthalmic follow-up examinations was evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 2, 2011
CompletedAugust 2, 2012
July 1, 2012
11 months
March 1, 2011
July 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Preoperative status
Plasma level of glycosylated hemoglobin (HbA1c)
Preoperative period
Preoperative status
Best-corrected visual acuity (BCVA),
Preoperative period
Secondary Outcomes (3)
Postoperative status
up to 1 year
Postoperative status
up to 1 year
Postoperative status
up to 1 year
Study Arms (3)
Never-treated group
The patients who had no previous ophthalmic examination until the first visit when vitreous surgery was prescribed
The non-compliant group
The patients with a history of missing ophthalmic examination over a one year period
The compliant group
The patients who had ophthalmic examinations at least once a year
Interventions
Vitrectomy. Diabetic retinopathy
Eligibility Criteria
The patients that underwent their first vitreous surgery for proliferaftive diabetic retinopathy
You may qualify if:
- One hundred and twenty-eight eyes of 94 patients that had undergone vitreous surgery for proliferative diabetic retinopathy.
- Type 2 diabetes.
You may not qualify if:
- The patients were not followed more than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyorin Eye Center
Mitaka, Tokyo, 181-8611, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Makoto Inoue, MD
Kyorin Eye Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
March 1, 2011
First Posted
March 2, 2011
Study Start
September 1, 2008
Primary Completion
August 1, 2009
Study Completion
April 1, 2010
Last Updated
August 2, 2012
Record last verified: 2012-07